Sign in
CompletedNo phase

Nutritional Treatment for the Amelioration of Traumatic Brain Injury

Key facts

Who runs it
Queen Mary University of London
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
32 people enrolled
Started
14 Oct 2021
Ended
30 Apr 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Souvenaid oral nutritional supplement (Nutricia)
Record updated
29 November 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult between 18 yrs and 80 yrs of age
  • Acute traumatic brain injury with confirmed radiological features

Who cannot take part

  • Concurrent active neurological disease
  • Allergies to fish oil/milk/soya
  • Medical history of galactosaemia
  • Non-traumatic aetiology to head injury
  • Unable to receive enteral nutrition
  • Craniectomy during admission (loss of integrity of skull convexity)
  • Pregnancy or breastfeeding

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To test the feasibility of administering a commercially available neurotrophic oral nutritional supplement (ONS) for adult patients with acute traumatic brain injury at the Royal London Hospital.

The 2 groups in the trial

  • ControlNo study treatment, for comparison

    Routine NHS care following traumatic brain injury

  • TreatmentTreatment being tested

    Routine NHS care following traumatic brain injury plus daily dose of test compound (oral nutritional supplement)

    Treatment: Souvenaid oral nutritional supplement (Nutricia)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 November 2024